QA: Aravive Inc in us_pharma/2017

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001513818_2018_Aravive_Inc.pdf

Logs

warning The stock price does not exist industry.us_generic {}

Graph

Absolute values for 0001513818, Aravive Inc

  xvar xval
0 AssetsCurrent 81,708,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 798,000
3 remainder_Assets 11,271,000
4 LiabilitiesCurrent 5,593,000
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 5,428,000
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 36,432,460
9 ResearchAndDevelopmentExpense 148,493,424
10 remainder_Expenses -10,945
11 remainder_Revenues 40,000,000
12 remainder_NetIncome -244,257
13 remainder_ComprehensiveNetIncome -349,305
  yvar yval
0 Assets 93,777,000
1 Liabilities 11,021,000
2 Expenses 184,914,939
3 Revenues 40,000,000
4 StockholdersEquity 82,756,000
5 NetIncome -145,159,196
6 ComprehensiveNetIncome -145,333,848
7 BaseVar 165,153,250
8 EconomicCapitalRatiobeforeLimitedLiability 0.669
9 EconomicCapitalRatio 2.03

Edgar->Model Mapping

Feature Distribution

Change over Time